Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FD.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FP.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FD.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FG.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.160NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JV.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XCYNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HK.16NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.1.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EK.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HV.1.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HV.1.6.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EF.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BU.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HV.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KK.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FY.1.4.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JG.3.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HK.27.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HV.1.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GK.1.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GK.8.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GK.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XENNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.54NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
DR.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.7.27NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.26NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CM.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.1.27NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.16NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.5.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.59NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.15NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.56NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KP.2.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XDP.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HN.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KL.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HK.24.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GK.2.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FL.1.5.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HE.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JM.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HV.1.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.27NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.7.22NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GP.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used